Last Updated: September 30, 2026

Patent: 8,906,368

✉ Email this page to a colleague

Summary for Patent: 8,906,368

Title:	Immunoglobulin preparations having increased stability
Abstract:	The present invention relates to a protein preparation having increased stability, comprising a stabilizer selected from the group consisting of non-polar and basic amino acids and having a pH of 4.0 to 5.2. The invention further relates to a pharmaceutical composition and a method of stabilizing protein preparations.
Inventor(s):	Reinhard Bolli, Gerhard Hodler, Regula Styger
Assignee:	CSL Behring AG
Application Number:	US13/618,757
Patent Claims:	see list of patent claims

Details for Patent 8,906,368

Glossary

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Approval Date	Patent No.	Expiredate
Csl Behring Ag	PRIVIGEN	immune globulin intravenous (human), 10% liquid	Injection	125201	26-Jul-07	8,906,368	2032-09-14
Csl Behring Ag	PRIVIGEN	immune globulin intravenous (human), 10% liquid	Injection	125201	2-Oct-09	8,906,368	2032-09-14
Csl Behring Ag	PRIVIGEN	immune globulin intravenous (human), 10% liquid	Injection	125201	7-Feb-13	8,906,368	2032-09-14
Csl Behring Ag	HIZENTRA	immune globulin subcutaneous (human), 20% liquid	Injection	125350	4-Mar-10	8,906,368	2032-09-14
Csl Behring Ag	HIZENTRA	immune globulin subcutaneous (human), 20% liquid	Injection	125350	13-Apr-23	8,906,368	2032-09-14
>Applicant	>Tradename	>Biologic Ingredient	>Dosage Form	>BLA	>Approval Date	>Patent No.	>Expiredate

International Patent Family for US Patent 8,906,368

Subscribe to access the full database, or Start Trial
Country	Patent Number	Estimated Expiration
Australia	2004290899	⤷ Start Trial
Canada	2545939	⤷ Start Trial
Denmark	1687028	⤷ Start Trial
Denmark	2364730	⤷ Start Trial
European Patent Office	1532983	⤷ Start Trial
European Patent Office	1687028	⤷ Start Trial
European Patent Office	2364730	⤷ Start Trial
>Country	>Patent Number	>Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.